5WA.SI - OUE Lippo Healthcare Limited

SES - SES Delayed Price. Currency in SGD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2018
31/12/2017
31/12/2016
31/12/2015
Total revenue
19,022
19,563
43,571
49,060
45,004
Cost of revenue
5,100
5,475
24,976
26,218
23,974
Gross profit
13,922
14,088
18,595
22,842
21,030
Operating expenses
Research development
-
-
-
-
-
Selling general and administrative
17,981
16,440
18,321
13,386
35,938
Total operating expenses
16,363
16,384
18,321
16,709
30,543
Operating income or loss
-2,441
-2,296
274
6,133
-9,513
Interest expense
8,136
10,133
15,885
27,299
25,150
Total other income/expenses net
-
-
-
-
-
Income before tax
-786
-7,540
-81,765
-75,816
15,027
Income tax expense
2,554
1,246
8,223
1,051
14,561
Income from continuing operations
-3,340
-8,786
-89,988
-76,867
466
Net income
-3,340
-9,318
-90,700
-76,847
368
Net Income available to common shareholders
-3,340
-9,318
-90,700
-76,847
368
Reported EPS
Basic
-
-0.00
-0.05
-0.04
0.00
Diluted
-
-0.00
-0.05
-0.04
0.00
Weighted average shares outstanding
Basic
-
2,614,788
1,896,074
1,896,074
1,887,195
Diluted
-
2,614,788
1,896,074
1,896,074
1,887,195
EBITDA
-
4,511
-63,813
-47,116
41,613